JAMDA
July 17, 2025
Showing 3171 - 3180 of 8451 results
JAMDA
April 27, 2024
Family Involvement among Oregon Adult Foster Home Residents, 2018–2023
To track the changes that occurred in family involvement among Oregon Adult Foster Home (AFH) residents following the COVID-19 pandemic and to examine the associations between home and resident characteristics and family involvement.
JAMDA
October 25, 2023
Fat Mass Accounts for Insulin Resistance Impact on Functional Decline and Mortality in Nondiabetic Older Adults
To assess the potential role of body composition in the association of insulin resistance (IR) with functional decline and mortality in nondiabetic older persons.
JAMDA
September 27, 2022
Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia
We aimed to examine the relationship between the fat-free mass index (FFMI; FFM/height) and appendicular skeletal muscle mass index (ASMI; ASM/height), measured using both bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA), and investigate the effects of age and obesity. We a...
JAMDA
December 8, 2023
Fatal Complication of Mouthguard Used to Treat Awake Bruxism in Patient with Frontotemporal Dementia
Awake bruxism is an understudied manifestation of frontotemporal dementia, yet awake bruxism can have fatal consequences in the aging population. This report presents a patient suffering from awake bruxism associated with frontotemporal dementia being treated with a mouthguard, which ultimately becomes lod...
JAMDA
July 10, 2015
Favorable Effect of Sympathetic Nervous Activity on Rehabilitation Outcomes in Frail Elderly
Previous studies have suggested the relationship between physical function, mortality, and autonomic nervous activity in frail elderly and that maintaining sympathetic nervous activity might lead to improved physical function and mortality in the elderly population. The aim of this study was to investigate...
Caring for the Ages
April 28, 2016
FDA Advisory Panel Favors Parkinson’s Disease Psychosis Drug
Caring for the Ages
July 31, 2015
FDA Approves Antibacterial Combination Drug
Caring for the Ages
May 27, 2016
FDA Approves First Drug To Treat Parkinson’s Psychosis
Caring for the Ages
August 29, 2015
FDA Approves First-in-Class Combo Drug for Heart Failure
